Drug Chatter -- Tracking biopharma stock chatter

Profile for Coherus BioSciences, Inc. (CHRS)

« Back to company index

CHRS Chatter Timeline

Stock Ticker for CHRS

Most Active Tweeters for CHRS

UserTweets
@TheMarketsDaily 6
@dakotafinancial 3
@SPNewsAnalysis 2
@TickerReport 2
@IRAMarketReport 2

Recent Tweets for CHRS

biotech_sector @biotech_sector
#CoherusBioSciences Coherus To Report Second Quarter 2017 Financial Results On August 7th . Read more: https://t.co/1FnskV237O $CHRS
July 24th 2017, 2:07pm
stockboardinc @stockboardinc
$CHRS Coherus BioSciences to Report Second Quarter 2017 Financial Results on August 7th... - https://t.co/Fp4TOVSS42
July 24th 2017, 9:07am
GNWLive @GNWLive
Coherus BioSciences to Report Second Quarter 2017 Financial Results on August 7th $CHRS https://t.co/sMuDOQ3olz
July 24th 2017, 9:07am
1MinuteStock @1MinuteStock
Wondering about risks of $CHRS? The 63-day volatility is 38.89% https://t.co/KctqISSBuC
July 22nd 2017, 1:07pm
1MinuteStock @1MinuteStock
Unicorn Bay rating for $CHRS is 2.05 out of 5. https://t.co/xxbOsjUFrV
July 22nd 2017, 12:07pm
dakotafinancial @dakotafinancial
138,440 Shares in Coherus BioSciences, Inc. $CHRS Acquired by Principal Financial Group Inc. https://t.co/F8h1l9hitI
July 22nd 2017, 8:07am
IRAMarketReport @IRAMarketReport
Principal Financial Group Inc. Purchases New Position in Coherus BioSciences, Inc. $CHRS https://t.co/dP67g9BHV6
July 22nd 2017, 8:07am
chaffeybreeze @chaffeybreeze
Principal Financial Group Inc. Purchases New Position in Coherus BioSciences, Inc. $CHRS https://t.co/uzoKvKrJG3
July 22nd 2017, 8:07am
tsilver_apex @tsilver_apex
$NVS planning resubmission of #biosimilar Neulasta for 2019 to address FDA CRL - seems $CHRS may still be first-to-market if all goes well
July 18th 2017, 7:07am
SPNewsAnalysis @SPNewsAnalysis
SG Americas Securities LLC Reduces Stake in Coherus BioSciences, Inc. $CHRS https://t.co/YGeMhLj0JS
July 17th 2017, 9:07am
emq_news @emq_news
SG Americas Securities LLC Reduces Stake in Coherus BioSciences, Inc. $CHRS https://t.co/I6sadoBmWK
July 17th 2017, 5:07am
TickerReport @TickerReport
SG Americas Securities LLC Reduces Stake in Coherus BioSciences, Inc. $CHRS https://t.co/0v7khZEM6U
July 17th 2017, 5:07am
TickerReport @TickerReport
SG Americas Securities LLC Reduces Stake in Coherus BioSciences, Inc. $CHRS https://t.co/hb2ChA5Hh6
July 17th 2017, 5:07am
TheMarketsDaily @TheMarketsDaily
Coherus BioSciences, Inc. $CHRS Given New $37.00 Price Target at Robert W. Baird https://t.co/gNJFUM8bu6
July 15th 2017, 7:07pm
DrSManian @DrSManian
$CHRS Biosimilars hot area for M&A - solid management team - recent hire Pat Obrien from $GILD Will have a solid tu… https://t.co/jFduV40rDX
July 15th 2017, 1:07pm
TheMarketsDaily @TheMarketsDaily
Coherus BioSciences $CHRS Given Daily Media Impact Rating of 0.01 https://t.co/lh3LsbuUjN
July 15th 2017, 9:07am
TheMarketsDaily @TheMarketsDaily
Regeneron Pharmaceuticals $REGN & Coherus BioSciences $CHRS Critical Review https://t.co/fVZh73ZRxb
July 14th 2017, 9:07pm
TheMarketsDaily @TheMarketsDaily
Coherus BioSciences’ $CHRS Buy Rating Reaffirmed at J P Morgan Chase & Co https://t.co/O6pyQKGh43
July 14th 2017, 7:07pm
TheMarketsDaily @TheMarketsDaily
Coherus BioSciences, Inc. $CHRS Earns “Outperform” Rating from Cowen and Company https://t.co/U2T1q2hUqU
July 14th 2017, 7:07pm
chaffeybreeze @chaffeybreeze
Coherus BioSciences, Inc. $CHRS Receives $42.71 Average Price Target from Analysts https://t.co/chNKG5biYj
July 14th 2017, 4:07am
IRAMarketReport @IRAMarketReport
Coherus BioSciences, Inc. $CHRS PT Lowered to $33.00 https://t.co/zcCnSIidXv
July 14th 2017, 1:07am
TheMarketsDaily @TheMarketsDaily
Coherus BioSciences, Inc. $CHRS Price Target Cut to $43.00 by Analysts at BMO Capital Markets https://t.co/iPOpUUOylp
July 14th 2017, 1:07am
dakotafinancial @dakotafinancial
Coherus BioSciences, Inc. $CHRS Shares Bought by Tudor Investment Corp ET AL https://t.co/tTgVsppnHB
July 13th 2017, 12:07pm
SPNewsAnalysis @SPNewsAnalysis
Bank of New York Mellon Corp Has $3.49 Million Stake in Coherus BioSciences, Inc. $CHRS https://t.co/PiNnixGODW
July 13th 2017, 8:07am
storminvestor @storminvestor
Bank of New York Mellon Corp Has $3.49 Million Stake in Coherus BioSciences, Inc. $CHRS https://t.co/rFoydtdbqI
July 13th 2017, 8:07am
midetimes @midetimes
Coherus BioSciences, Inc. $CHRS Shares Bought by Tudor Investment Corp ET AL https://t.co/8JSvkOyFkR
July 13th 2017, 7:07am
dailypoliticaln @dailypoliticaln
Bank of New York Mellon Corp Has $3.49 Million Stake in Coherus BioSciences, Inc. $CHRS https://t.co/qUfaKcgXsE
July 13th 2017, 5:07am
wboscoho @wboscoho
Nibble some $CHRS even though biosimilars are not in vogue these days
July 12th 2017, 2:07pm
OncologyInfo @OncologyInfo
Here's What's Behind Amgen, Inc.'s 10.2% Gain in June @themotleyfool #stocks $AMGN, $CHRS https://t.co/wTBJjr3moY
July 12th 2017, 11:07am
dakotafinancial @dakotafinancial
Coherus BioSciences, Inc. $CHRS Receives Consensus Recommendation of “Buy” from Analysts https://t.co/51zjeI8QpZ
July 12th 2017, 12:07am
Emylers @Emylers
CHRS Stock 13.38 Coherus Bio Cmn Stk $CHRS Hit 165,925 52 week lows as of +2.71%. Currently trading at 13.38 + https://t.co/BspgdSuX5c
July 11th 2017, 11:07am
MBAbstract @MBAbstract
Here's What's Behind Amgen, Inc.'s 10.2% Gain in June @themotleyfool #stocks $AMGN, $CHRS https://t.co/hA5bD7S55F
July 10th 2017, 2:07pm
langanstocks @langanstocks
Emylers: CHRS Stock 13.15 Coherus Bio Cmn Stk $CHRS Hit 90,339 52 week lows as of +0.38%. Currently trading a https://t.co/BvaQYX2YmH
July 10th 2017, 12:07pm
Emylers @Emylers
CHRS Stock 13.15 Coherus Bio Cmn Stk $CHRS Hit 90,339 52 week lows as of +0.38%. Currently trading at 13.15 -0 https://t.co/pDTYAGK9xz
July 10th 2017, 11:07am
TheMarketsDaily @TheMarketsDaily
Coherus BioSciences $CHRS Receiving Somewhat Positive Press Coverage, Study Finds https://t.co/dMfLabp3ZG
July 10th 2017, 10:07am
whotrades @whotrades
Here's What's Behind Amgen, Inc.'s 10.2% Gain in June https://t.co/N2M0zDzXXT $AMGN $CHRS
July 10th 2017, 10:07am
SleekMoneycom @SleekMoneycom
Coherus BioSciences $CHRS Receiving Somewhat Positive Press Coverage, Study Finds https://t.co/C3ADb2cbaC
July 10th 2017, 7:07am
dakotafinancial @dakotafinancial
Coherus BioSciences, Inc. $CHRS Shares Bought by Wells Fargo & Company MN https://t.co/3X9KThX7bp
July 10th 2017, 7:07am
midetimes @midetimes
Coherus BioSciences, Inc. $CHRS Shares Bought by Wells Fargo & Company MN https://t.co/Sil34yjAfh
July 10th 2017, 4:07am
midetimes @midetimes
Coherus BioSciences, Inc. $CHRS Given Average Rating of “Buy” by Analysts https://t.co/vToudcLwBd
July 9th 2017, 5:07pm
dailymailtimes @dailymailtimes
Coherus BioSciences, Inc. $CHRS Given Average Rating of “Buy” by Analysts https://t.co/Vez98Enev2
July 9th 2017, 5:07pm
midetimes @midetimes
Highbridge Capital Management LLC Takes Position in Coherus BioSciences, Inc. $CHRS https://t.co/xbl8C5aMSd
July 9th 2017, 8:07am
midetimes @midetimes
Coherus BioSciences, Inc. $CHRS Stake Boosted by Gotham Asset Management LLC https://t.co/4GsvFfF3QC
July 9th 2017, 8:07am
storminvestor @storminvestor
Coherus BioSciences, Inc. $CHRS Expected to Post Earnings of -$1.29 Per Share https://t.co/XqSfKsfP7j
July 8th 2017, 6:07pm
WatchlistN @WatchlistN
Coherus BioSciences, Inc. $CHRS Expected to Post Earnings of -$1.29 Per Share https://t.co/YeqYjjh0vP
July 8th 2017, 6:07pm
SPNewsAnalysis @SPNewsAnalysis
Coherus BioSciences, Inc. $CHRS Expected to Post Earnings of -$1.29 Per Share https://t.co/ZgZ9EUPLbn
July 8th 2017, 6:07pm
BioPharmaDive @BioPharmaDive
$CHRS loses another partner on its Enbrel biosimilar https://t.co/YY9zsbA5H2 $AMGN
July 8th 2017, 5:07pm
TranscriptDaily @TranscriptDaily
Coherus BioSciences, Inc. $CHRS Receives $38.50 Average PT from Brokerages https://t.co/urq0WgxDZz
July 7th 2017, 7:07pm
emq_news @emq_news
Coherus BioSciences, Inc. $CHRS Receives $38.50 Average PT from Brokerages https://t.co/FknNZ9Uumc
July 7th 2017, 7:07pm
TickerReport @TickerReport
Coherus BioSciences, Inc. $CHRS Receives $38.50 Average PT from Brokerages https://t.co/KWn9dPcOI4
July 7th 2017, 7:07pm

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.